XIFAXAN INSTANT SAVINGS CARD

×

With the XIFAXAN Instant Savings Card, eligible patients* with commercial insurance covering Xifaxan may pay no more than $0 for their Xifaxan prescription.

*Eligibility Criteria, Terms and Conditions: This offer is only valid for patients with commercial insurance, including commercially insured patients without coverage for Xifaxan. Patients without commercial insurance are not eligible. Salix Pharmaceuticals will pay the patient’s co-payment for each eligible prescription fill using the savings card up to a maximum amount of $300 per fill on quantity of 1-20 pills dispensed, $500 per fill on quantity of 21-41 pills dispensed, $1,000 per fill on quantity of 42 pills and more dispensed. For eligible commercially insured patients without coverage for Xifaxan, the patient must pay the first $50 of out-of-pocket expense and then Salix Pharmaceuticals will pay the remaining out-of-pocket expense up to the maximum amount of $300 per fill on quantity of 1-20 pills dispensed, $500 per fill on quantity of 21-41 pills dispensed, $1,000 per fill on quantity of 42 pills and more dispensed. Patient is responsible for all additional costs and expenses after application of the maximum benefits. This savings card can be used up to 12 times per calendar year. This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. This offer is only good in the USA at participating retail pharmacies. This offer cannot be redeemed at other locations, including government-subsidized clinics or facilities. This offer is not valid where otherwise prohibited, taxed, or otherwise restricted. Patient is responsible for reporting receipt of copay assistance to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the copay card, as may be required. This offer cannot be combined with other offers. This card has no cash value. No other purchase is necessary. This offer is nontransferable. No substitutions are permitted. This card is not health insurance. You understand and agree to comply with the terms and conditions of this offer as set forth above. Salix Pharmaceuticals reserves the right to rescind, revoke, or amend this offer at any time without notice. This offer expires on December 31, 2017.

Loading...
Loading...

All personal information will be kept confidential and will not be shared with any third parties other than Salix Pharmaceuticals and its designated partners. <br/><br/><a class="blue" style="font-weight: normal !important;color: rgb(51, 122, 183);font-family: 'HelveticaNeue' !important;font-size:16px; text-decoration: underline;" href="http://www.valeant.com/privacy" target="_blank">View</a><span style="color: rgb(51, 122, 183);font-family: 'HelveticaNeue' !important;font-size:16px;font-weight: normal !important;"> our full Privacy Policy.</span>
<span style="color:#777;font-weight: normal; font-size: 14px;font-family: 'Proxima Nova' !important;">Please enter the letters and numbers below for security purposes.</span>


XIFI.0246.USA.17

INDICATIONS

XIFAXAN® (rifaximin) 550 mg tablets are indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults and for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults.

IMPORTANT SAFETY INFORMATION
  • XIFAXAN is not for everyone. Do not take XIFAXAN if you have a known hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN
  • If you take antibiotics, like XIFAXAN, there is a chance you could experience diarrhea caused by an overgrowth of bacteria (C. difficile). This can cause symptoms ranging in severity from mild diarrhea to life-threatening colitis. Contact your healthcare provider if your diarrhea does not improve or worsens.
  • Talk to your healthcare provider before taking XIFAXAN if you have severe hepatic (liver) impairment as this may cause increased effects of the medicine.
  • Tell your healthcare provider if you are taking drugs called P-glycoprotein inhibitors (such as cyclosporine) because using these drugs with XIFAXAN may lead to an increase in the amount of XIFAXAN absorbed by your body.
  • If you are pregnant, planning to become pregnant, or nursing, talk to your healthcare provider before taking XIFAXAN because XIFAXAN may cause harm to an unborn baby or nursing infant.
  • In clinical studies, the most common side effects of XIFAXAN were:
    • HE: peripheral edema (swelling, usually in the ankles or lower limbs), nausea (feeling sick to your stomach), dizziness, fatigue (feeling tired), and ascites (a buildup of fluid in the abdomen).
    • IBS-D: Nausea (feeling sick to your stomach) and an increase in liver enzymes.

Please click here for full Prescribing Information for XIFAXAN.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For product information, adverse event reports, and product complaint reports, please contact:
Salix Product Information Call Center
Phone: 1-800-321-4576
Fax: 1-510-595-8183
Email: salixmc@dlss.com

Use of this site signifies your agreement to the Legal Notice and Privacy Policy.
Salix Pharmaceuticals
400 Somerset Corporate Boulevard | Bridgewater, NJ 08807  

The Xifaxan 550 mg product and the Xifaxan trademark are licensed by Alfa Wassermann S.p.A. to Salix Pharmaceuticals or its affiliates. The Gut Guy character is a copyright and trademark of Salix Pharmaceuticals or its affiliates.

XIFI.0155.USA.17
See More
INDICATIONS

XIFAXAN® (rifaximin) 550 mg tablets are indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults and for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults.

IMPORTANT SAFETY INFORMATION
  • XIFAXAN is not for everyone. Do not take XIFAXAN if you have a known hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN
  • If you take antibiotics, like XIFAXAN, there is a chance you could experience diarrhea caused by an overgrowth of bacteria (C. difficile). This can cause symptoms ranging in severity from mild diarrhea to life-threatening colitis. Contact your healthcare provider if your diarrhea does not improve or worsens.
  • Talk to your healthcare provider before taking XIFAXAN if you have severe hepatic (liver) impairment as this may cause increased effects of the medicine.
  • Tell your healthcare provider if you are taking drugs called P-glycoprotein inhibitors (such as cyclosporine) because using these drugs with XIFAXAN may lead to an increase in the amount of XIFAXAN absorbed by your body.
  • If you are pregnant, planning to become pregnant, or nursing, talk to your healthcare provider before taking XIFAXAN because XIFAXAN may cause harm to an unborn baby or nursing infant.
  • In clinical studies, the most common side effects of XIFAXAN were:
    • HE: peripheral edema (swelling, usually in the ankles or lower limbs), nausea (feeling sick to your stomach), dizziness, fatigue (feeling tired), and ascites (a buildup of fluid in the abdomen).
    • IBS-D: Nausea (feeling sick to your stomach) and an increase in liver enzymes.

Please click here for full Prescribing Information for XIFAXAN.

You are leaving Xifaxan's Consumer Web Site

You are now going to be transferred to the Health Care Providers portal

Proceed Cancel
×